Apolipoprotein E Genotype and Cerebral Amyloid Angiopathy‐related Hemorrhage
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
A bstract: Following the identification of the role of the apolipoprotein E (APOE) gene polymorphism in Alzheimer's disease (AD), this gene was examined in cerebral amyloid angiopathy (CAA). As in AD, the APOE ɛ4 allele was found to be associated with CAA. Lobar intracerebral hemorrhage is the major clinical manifestation of CAA. Initial studies on a small number of patients with CAA‐related hemorrhage (CAAH) identified overrepresentation of APOE ɛ4. However, it became clear that confounding bias from concomitant AD and the need for pathologically confirmed cases of CAAH would also have to be considered. A larger series of pathologically confirmed cases of CAAH, also assessed for AD pathology, found a surprising overrepresentation of the APOE ɛ2 allele. Because of the association between CAA and AD, it might have been predicted that patients with CAAH would have a low, rather than a high, ɛ2 frequency. The overrepresentation of APOE ɛ2 was present both in patients with and without AD, whereas a high ɛ4 frequency correlated with concomitant AD. Further studies found that overrepresentation of APOE ɛ2 is specific for CAAH and is not found in intracranial hemorrhages due to other causes. In CAAH, APOE ɛ2 may interact with putative risk factors for hemorrhage, including antiplatelet/anticoagulant medication, minor head trauma, and hypertension. Several microvascular abnormalities in amyloid‐laden blood vessels have been assumed to antedate CAAH and increase its likelihood. APOE ɛ2 has now been found to be associated with some of these vascular abnormalities, specifically a “double‐barrel” appearance and fibrinoid necrosis. The currently favored interpretation is that APOE ɛ4 enhances deposition of amyloid‐β protein in the walls of cerebral blood vessels, whereas ɛ2 is a risk factor for hemorrhage from amyloid‐laden blood vessels by promoting specific “CAA‐associated vasculopathies.”
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157
Weller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Cerebral Amyloid Angiopathy: The Vascular Pathology and Complications
MANDYBUR, T. I. (1986) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198601000-00007 · Cited by 304
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
Greenberg, S. M., Vonsattel, J.-P. G., Segal, A. Z., Chiu, R. I., Clatworthy, A. E., Liao, A., Hyman, B. T., & Rebeck, G. W. (1998) · Neurology · doi:10.1212/wnl.50.4.961 · Cited by 267
Olichney, J. M., Hansen, L. A., Galasko, D., Saitoh, T., Hofstetter, C. R., Katzman, R., & Thal, L. J. (1996) · Neurology · doi:10.1212/wnl.47.1.190 · Cited by 216
McCarron, M. O., Nicoll, J. A. R., Stewart, J., Ironside, J. W., Mann, D. M. A., Love, S., Graham, D. I., & Dewar, D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00005 · Cited by 160
Self-citation
Cited by
Alzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680
“, 1996), whereas the ε2 allele has been linked to greater risk of CAA-associated vasculopathy and CNS hemorrhage (Nicoll et al., 1997; Greenberg et al., 1998; McCarron and Nicoll, 2000; Nicoll and McCarron, 2001).”
BackgroundCan Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis
Eckman, M. H., Rosand, J., Knudsen, K. A., Singer, D. E., & Greenberg, S. M. (2003) · Stroke · doi:10.1161/01.str.0000078311.18928.16 · Cited by 304
Monoaminergic neuropathology in Alzheimer’s disease
Šimić, G., Babić Leko, M., Wray, S., Harrington, C. R., Delalle, I., Jovanov-Milošević, N., Bažadona, D., Buée, L., de Silva, R., Di Giovanni, G., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.001 · Cited by 289
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage
Biffi, A., Sonni, A., Anderson, C. D., Kissela, B., Jagiella, J. M., Schmidt, H., Jimenez‐Conde, J., Hansen, B. M., Fernandez‐Cadenas, I., Cortellini, L., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22134 · Cited by 276
Preston, S. D., Steart, P. V., Wilkinson, A., Nicoll, J. A. R., & Weller, R. O. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00424.x · Cited by 239
Self-citationThe role of APOE in cerebrovascular dysfunction
Tai, L. M., Thomas, R., Marottoli, F. M., Koster, K. P., Kanekiyo, T., Morris, A. W. J., & Bu, G. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1547-z · Cited by 231
Suri, S., Heise, V., Trachtenberg, A. J., & Mackay, C. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.010 · Cited by 183
“Both the !2 and !4 alleles are associated with a high risk of developing cerebral amyloid angiopathy-related haemorrhage (Biffi et al., 2011; Greenberg, 1998; McCarron and Nicoll, 2000; McCarron et al., 1999; Nicoll et al., 1997); !4 by increasing vascular amyloid deposition, and !2 by causing specific changes in vasc…”
BackgroundPopulation studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review
Keage, H. A., Carare, R. O., Friedland, R. P., Ince, P. G., Love, S., Nicoll, J. A., Wharton, S. B., Weller, R. O., & Brayne, C. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-3 · Cited by 181
“The ε4 allele of the APOE gene has been reported to be a risk factor for CAA as it is for AD [64-68] and this was seen in two of the population-based studies reviewed here [13,35].”
Self-citationPathogenesis of cerebral amyloid angiopathy
Rensink, A. A. M., de Waal, R. M. W., Kremer, B., & Verbeek, M. M. (2003) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.001 · Cited by 159
APOE and cerebral amyloid angiopathy in community-dwelling older persons
Yu, L., Boyle, P. A., Nag, S., Leurgans, S., Buchman, A. S., Wilson, R. S., Arvanitakis, Z., Farfel, J. M., De Jager, P. L., Bennett, D. A., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.008 · Cited by 123
Prevalence of cortical superficial siderosis in a memory clinic population
Zonneveld, H. I., Goos, J. D. C., Wattjes, M. P., Prins, N. D., Scheltens, P., van der Flier, W. M., Kuijer, J. P. A., Muller, M., & Barkhof, F. (2014) · Neurology · doi:10.1212/wnl.0000000000000150 · Cited by 78
APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
Mirza, S. S., Saeed, U., Knight, J., Ramirez, J., Stuss, D. T., Keith, J., Nestor, S. M., Yu, D., Swardfager, W., Rogaeva, E., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008377 · Cited by 67
Sellal, F., Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160709 · Cited by 43
“was associated with an increased risk of sporadic 455 CAA [27], while it has been suggested that APOE 456 2 could be a risk factor for ICH in vessels with 457 amyloid charge [28].”
Metadata
- Authors
- McCARRON, M. O., & NICOLL, J. A. R.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 903
- Issue
- 1
- Pages
- 176-179
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2076215149
- Cited by
- 99
- References
- 12
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.